Multiple muscular calcifications in a 68-year old male;Múltiples calcificaciones musculares en un varón de 68 años de edad

Revista Clinica Espanola

Volumn 202, Issue 12, 2002, Pages 669-671

  Iglesias Oliva, L ^a   Perez Roji G ^a   Perez Llantada Amunarriz E ^a   Gonzalez Mandly A ^a   Garcia Castrillo Riesco L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; HEMOGLOBIN;

AGED; ARTICLE; BRAIN CYSTICERCOSIS; BRAIN SCINTISCANNING; CALCIFICATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPILEPSY; HUMAN; JOINT RADIOGRAPHY; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MUSCLE DISEASE; OSTEOARTHRITIS;

EID: 0036948856     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0014-2565(02)71178-8     Document Type: Article

References (8)

1. Webbe G. Human cysticercosis. Parasitology, pathology, clinical manifestations and available treatment. Pharmacol Ther 1994;64:175-200.
2. Garg RK. Neurocysticercosis. Postgrad Med J 1998;74:321-6.
3. Medina MT, Rosas E, Rubio F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:325-7.
4. García-Albea E. Cisticercosis en España. Algunos datos epidemiológicos. Rev Clin Esp 1989;184:3-6.
5. Terraza S, Pujol T, Gascón J, Corachán M. Neurocisticercosis: θ?una enfermedad importada? Med Clin (Barc) 2001;116:261-3.
6. Salgado P, Rojas R, Sotelo J. Cysticercosis. Clinical classification based on imaging studies. Arch Intern Med 1997;157:1991-7.
7. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparision between albendazole and praziquantel. Arch Neurol 1992;49:290-4.
8. Carpio A, Santillán F, León P, Flores C, Hauser W. Is the course of neurocysticercosis modified by treatment with antihelmintic agents? Arch Intern Med 1995;155:1982-8.